Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to determine if treatment with HRS-1167 alone is safe, tolerable, and
has anti-cancer activity in patients with advanced solid tumors.